LGND
Ligand Pharmaceuticals Incorporated
NASDAQ · Healthcare · Biotechnology · US
$287.44
−0.79%Margins
Gross margin
98.6%
EBITDA margin
94.2%
EBIT margin
34.7%
Net margin
67.9%
FCF margin
45.2%
20.4%
Return on equity
9.0%
Return on assets
4.8%
Return on invested capital
0.16x
Asset turnover
$131.6M
Cash from operations
$68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026